Abbott India announces director resignation, new appointment

Abbott India Limited confirmed that Ambati Venu will resign as director, effective December 31, 2025, to pursue an external career opportunity. The company stated no other material reasons contributed to his resignation beyond those mentioned in his letter.

Concurrently, the board of directors, based on a recommendation from the nomination and remuneration committee, approved the appointment of Vivek Mohan as an additional (non-executive) director, with his tenure commencing on January 1, 2026. Shareholders will be asked to approve this appointment via a postal ballot.

Mohan is currently Abbott’s vice president, established pharmaceuticals, India. His extensive career at Abbott, which began in 1992, includes leadership roles across the US, UK, India, Indonesia, and the Middle East, along with significant experience in corporate global marketing. He holds a bachelor of science in microbiology and an M.B.A. in international business and marketing. The company affirmed that Mohan is not debarred from holding a directorship and is not related to any existing directors, key managerial personnel, or senior management.